Skip to content
EN TR

Condition

Pancreatic Cancer

Pancreatic Cancer

Pancreatic cancer refers to malignant tumors arising in the pancreas. Pancreatic ductal adenocarcinoma is the most common type.

Pancreatic Cancer

Pancreatic cancer refers to malignant tumors arising in the pancreas. Pancreatic ductal adenocarcinoma is the most common type.

What is this condition?

Tumor location in the head, body or tail and its relationship with vessels influence surgical planning.

Signs and symptoms

Jaundice, dark urine, pale stools, upper abdominal/back pain, appetite loss and weight loss can occur.

Diagnostic assessment

Pancreas-protocol CT, MRI, endoscopic ultrasound and tissue sampling when needed are used for diagnosis and staging.

General treatment framework

Treatment may combine surgery, systemic therapy and selected radiotherapy approaches depending on resectability.

Role of surgery

Head tumors may require a Whipple procedure; body/tail tumors may require distal pancreatectomy.

Selected academic work

These publications demonstrate academic work related to the topic; they are not the sole source of current treatment standards.

  • PUB-2025-01 — 2025 — Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, and Prognosis Prediction. — https://doi.org/10.3390/jcm14113719
  • PUB-2025-02 — 2025 — The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study. — https://doi.org/10.3390/medicina61020168

Frequently Asked Questions

View All Questions
Can every pancreatic cancer be operated on?

No. Resectability depends on stage and vascular relationships.

Which operation is used for pancreatic head cancer?

A Whipple procedure is considered in suitable patients.

Can chemotherapy come before surgery?

Yes. Some treatment plans use preoperative systemic therapy.

Selected Publications

View All Publications

Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, and Prognosis Prediction.

Journal of clinical medicine, 2025

↗

The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study.

Medicina (Kaunas, Lithuania), 2025

↗
Sources

2 verified source references.

Last Updated

10.09.2026

Information Notice

This content is for general health information and is not individual diagnosis or treatment advice.

Contact and Appointments

Appointments, Patient Information and Professional Communication

For appointment requests, patient information and professional communication, you may contact us through the channels below.

All inquiries are reviewed through secretarial coordination and responded to with appropriate guidance.

WhatsApp

Send a Message

For first contact with the secretariat and brief information sharing.

View on Map